BridgeBio Gene Therapy
BridgeBio’s mission is to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio Gene Therapy is the arm of BridgeBio that is dedicated to developing AAV gene therapies to accomplish this mission. We currently have two AAV gene therapies in ongoing clinical trials, and several programs in our preclinical pipeline.